Purchase Short-Term Access

Do the Benefits of Prolonged Low-Molecular-Weight Heparin Treatment Outweigh the Harms in Hospitalized Patients Who Are Bedbound?
Annals of Internal Medicine 2010;153:I-50. doi:10.7326/0003-4819-153-1-201007060-00002

Purchase Online access to this article for 24 hours
Buy Now

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.